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Abstract
Aims: To construct and evaluate rats’ tolerogenic dendritic cells (DC) through induction by NF-κB Decoy method.
Methods: GM-CSF and IL-4 were used to transform rats’s monocytes into DC, and DC were stimulated with LPS, NF-
κB Decoy ODN, and loaded with Bovine TypeⅡCollagen. The following methods were employed to phenotype DC: 1) 
Observation of  cell morphology; 2) Evaluation of  cell viability using trypan blue staining; 3) Purity determination of  DC 
through detection of  specific markers OX-62; 4) Evaluation of  mature state of  DC via the determination of  the expression 
of  CD80 and CD86; 5) Determination of  stimulation capability towards the proliferation of  lymphocyte and the secretion 
of  INF-r and IL-10. 
Results: The activity of  DC was more than 92%, and the expression of  OX-62 was more than 70%. Most of  DC exhibited 
the phenotype of  CD80+/CD86-. Compared with control group and LPS-stimulation group, the less mature adhered cells and 
hairlike DC were observed in NF-κB decoy group. Significant reduction (p<0.05) was observed for the positive expression 
and extension of  CD80 and CD86 in cell surface. After loaded with calf  type II collagen, the low expression of  CD80 and 
CD86 remains to be existed. The stimulation capability of  DC towards lymphocyte in NF-κB decoy group was lower than 
that in control group (p<0.05) and LPS stimulation group (p<0.05).  
Conclusion: NF-κB Decoy ODN method can be successfully applied for construct rats’ tolerogenic dendritic cells (DC) 
with stable morphology and phenotype. The tolerogenic DC exhibited immature immune phenotype, and low capability to 
stimulate lymphocytes. 
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Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune 
disease influencing multiple joints such as hands, 
wrists and feet. The main pathological changes for RA 
patients contains infiltration of  inflammatory cells, 







[1,2]. To date, the clinical therapeutic drugs for 
treatment of  RA commonly focus on the inhibition of  
immune system, which provides big risk of  infectious 
diseases. Searching of  new therapeutic methods for RA 
is necessary and important.
Generally, the initiation of  RA has been closely related 
with the abnormal antigen presenting cell (APC), which 
will result in the activation of  T cells, especially Th1 
and Th17 cells [3]. Dendritic cells (DC) is a kind of  
APC, and play a key role in regulation of  the induction 
of  the differentiation naive T cells towards Th cells 
through increased expression of  adhesion molecules 
and cytokine receptors as well as the production of  
cytokines [4]. Compared with mature DCs, immature 
DCs have
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been commonly loaded with antigen and manipulated 
to generate tolerogenic DCs and suppress autoimmune 
responses both in vivo and in vitro. Various manipulations 
have been applied to generate tolerogenic phenotype, 
including regulation of  molecular targets on DCs, uptake 
of  apoptotic cells, and genetic engineering strategy. For 
example, the immunoglobulin-like transcript (ILT) family 
contains a group of  activating and inhibitory receptors, 
and some of  them play a role in tolerance induction 
[5]. The upregulation of  ILT3 and ILT4 receptors on 
human DCs renders them tolerogenic. Direct induction 
using low dose of  GM-CSF and transfection of  IL-4 
gene can also adapted to make tolerogenic DCs.
The present study aims to induce DC using monocytes 
isolated from rats’ spleen. The new reported method 
Decoy strategy was utilized, in which Nuclear factor-
kappa B (NF-κB) Decoy oligodeoxynucleotide (ODN) 
was imported into the cells to prevent the activation 
of  NF-κB. After loaded with calf  type II collagen, 
some important phenotype was observed, including 
morphological characteristics, the expression of  
costimulatory molecules in cell surface, and stimulation 
capability towards lymphocytes. 
Materials and Methods
Chemicals and reagents
Bovine Type Collagen, MTT formazan, HEPES, and 
Lipolysaccharides(LPS) were purchased from Sigma 
company (St. Louis, MO). PE conjugated anti-rat 
CD80(B7-1), PE conjugated anti-rat CD103(αE2,DC 
marker) and FITC conjugated anti-rat CD86(B7-2) 
were obtained from eBioscience (San Diego, CA). 
Recombinant rat GM-CSF and IL-4 were purchased 
from peprotech company. RPMI medium was obtained 
from GIBCO (Maryland, USA). Mitomycin C was 
obtained from Suolaibao company. 
Isolation of  rats’ spleen monocytes
Female SD rats (250-320 g, 7-8 months) and male 
Wistar rats (300g, 7 months) were obtained from 
the experimental animal center of  Guiyang Medical 
University. The spleen was taken from SD rats, and 
washed using RMPI1640 medium for three times. The 
spleen was grinded and washed with d-Hanks. The 
spleen cells were collected through filteration, and 
monocytes were obtained through density gradient 
centrifugation. The monocytes were cultured, and 
trypan blue staining was used to show the cell viability 
to be more than 85%. 
The induction for the formation of  dendritic cells 
(DC) 
The monocytes were incubated with RMPI 1640 
containing GM-CSF (30 ng/mL) and IL-4 (20 ng/
mL). The cells were divided into the following groups: 
1) Control group 2) LPS stimulation group: After the 
culture of  DC cells for 7 days, 10μg/mL of  LPS was 
added to stimulate DC. 3) Decoy induction group: 
5 μmol/L of  NF-κB Decoy ODN was added at the 
beginning of  DC culture. 4) LPS stimulation+Decoy 
induction group: 5 μmol/L of  NF-κB Decoy ODN was 
added at the beginning of  DC culture, and 10μg/mL 
of  LPS was added to stimulate DC after 7 day culture. 
5) Loaded with Bovine TypeⅡCollagen after Decoy 
induction group: 5 μmol/L of  NF-κB Decoy ODN was 
added at the beginning of  DC culture, and 50μg/mL of  
calf  type II collagen (pH=7.2). The synthesis of  NF-
κB Decoy ODN was according to previous description 
with some modifications [6].  
    
The observation of  cell morphology
The inverted phase contrast microscope was used to 
observe the cell morphology of  DC. The smear cytology 
was also performed, and cell morphology was observed 
after staining with Giemse. 
The detection of  specific markers using flow 
cytometric analysis
The cells number was diluted 1×106 cells/tube, and the 
corresponding antibody was added to undergo reaction 
for 40 min. The added quantity of  PE-OX-62, PE-
CD80, and FITC-CD86 was 1.5μL/106 cells, 2μL/106 
cells, and 0.8μL/106 cells, respectively.  
The flow cytometric analysis was carried out as 
previously described [7].
Investigation of  stimulation capability of  DC 
towards lymphocytes
The DCs were cultured for 8 days, and then mitomycin 
C (3g/L) was added and cultured for another 30 min. 
The cells were diluted to 2×105/mL with RMPI1640 
as stimulation cells. The spleens of  wistar rats were 
taken, and the same method for DC preparation was 
used to prepare the reaction cells. The mixed ratio 
between stimulation cells and reaction cells was 1:5 as 
previously described [8]. After 68h incubation, 50 μL 
of  supernatant was analyzed for the concentration of  
IFN-r and IL-10. 20 μL of  MTT was added in well, 
and after the incubation for 4h at 37oC, the medium 
was discarded. 100 μL of  DMSO was added, and OD 
values were read at 570 nm.
Statistical analysis
The statistical analysis was performed using SPSS11.5 
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software, and Statistical differences were evaluated using 
the two-tailed Student’s t-test and considered significant 
at the *p < 0.05, **p <0.01 level.
Results
The cell morphology of  DC
After 72h incubation, cell colony was formed, and the 
volume of  some cells increased. The cell morphology 
was star or round, and a few cells exhibited hairlike 
morphology. There was no significant difference for the 
cell morphology. After 5 day culture, there were more 
adhered cells in decoy group than control group. The 
addition of  LPS significantly increased the growth of  
DC. After 8 day culture, there was more hairlike DC in 
LPS stimulation group than that in other groups. 
The expression of  OX62 in cell surface
As shown in Fig. 1, the expression ratio of  OX62 was 
72.6%, 85.2%, 87.6%, 79.6% and 86.6% for control, LPS 
stimulation, Dexoy induction, LPS stimulation+Decoy 
induction, and Bovine TypeⅡCollagen-Decoy-DC 
groups, respectively.
Fig.1  The expression of  OX-62 on DCs. (A) negative 
control; (B) control; (C) LPS stimulation; (D) NF-κB 
Decoy ODN induction; (E) LPS stimulation+NF-κB 
Decoy ODN induction; (F) Loaded with Bovine TypeⅡCollagen after Decoy induction 
The expression of  CD80 and CD86 
The Fig. 2 and Fig. 3 were representative figures of  the 
expression of  CD80 and CD86, and the table 1 gave a 
conclusion of  the positive expression ratio and intensity 
for CD80 and CD86. 
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    Control 0.74±0.05 3019±306 0.07±0.06 341±262
LPS stimulation 0.86±0.13 5427±768* 0.41±0.20* 1497±160*
NF-κB Decoy 0.53±0.17 1540±339*# 0.01±0.01# 109±163#
LPS stimulation+ 
NF-κB Decoy
0.65±0.17 2350±1100# 0.03±0.02# 537±266#
Bovine Type Ⅱ 
Collagen-Decoy
0.66±0.09 2007±422*# 0.05±0.04# 240±118#
Note: *, p<0.05, compared with control group; #, p<0.05, compared with LPS stimulation group.
For the positive expression ratio of  CD80, there was 
no significant among these groups. For the expression 
intensity, the intensity in Decoy group and Bovine 
TypeⅡCollagen-Decoy group was lower than that in 
control group (p<0.05). Although the LPS stimulation 
can increase the expression intensity of  CD80 for decoy 
induction, the intensity value in LPS stimulation+decoy 
induction group remained to be lower than LPS 
stimulation group (p<0.05). DC in the control 
group nearly did not express CD86. LPS stimulation 
significantly increased the positive expression ratio 
of  CD86 (p<0.01). There is no significant difference 
between Decoy, LPS stimulation+Decoy, Bovine 
TypeⅡCollagen-Decoy group and control group 
(p>0.05). The expression of  CD86 showed low intensity 
in control, decoy, LPS stimulation+decoy, and Bovine 
TypeⅡCollagen-decoy groups, and there were no 
significantly difference among these groups (p>0.05). 
The expression intensity of  CD86 in LPS stimulation 
group was significantly higher than that in other group 
(p<0.01).
Fig. 2 The representative flow cytometric histograms 
for the expression of  CD80. (A) control; (B) LPS 
stimulation; (C) NF-κB Decoy ODN induction; (D) 
LPS stimulation+NF-κB Decoy ODN induction; (E) 
Loaded with Bovine TypeⅡCollagen after Decoy 
induction.
629 African Health Sciences Vol 14 Issue 3, September 2014
Fig. 3 The representative flow cytometric histograms for the expression of  CD86. (A) control; (B) LPS stimulation; 
(C) NF-κB Decoy ODN induction; (D) LPS stimulation+NF-κB Decoy ODN induction; (E) Loaded with Bovine 
TypeⅡCollagen after Decoy induction
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Evaluation of  stimulation capability of  DC towards 
lymphocytes
The influence of  DC towards proliferation capability 
of  lymphocytes was listed in Table 2. Compared 
with control group, the proliferation capability of  
lymphocytes in LPS stimulation group was much higher 
(p<0.01), and the proliferation capability of  lymphocytes 
in decoy induction group was much lower (p<0.05). 
After stimulation by LPS, the stimulation capability 
of  DC towards lymphocytes in decoy induction group 
increased. However, the stitulation capability remains to 
be lower than LPS stimulation group (p<0.001). The 
addition of  serum of  healthy person exhibited stronger 
stimulation capability than that for the addition of  
Bovine TypeⅡCollagen (p<0.001).
Table 2 Evaluation of  stimulation capability of  DC towards lymphocytes



















Note: *, p<0.05, compared with control group; #, p<0.05, compared with LPS stimulation group; △,p<0.05, 
compared with Decoy induction group; ※, p<0.05, compared with Bovine TypeⅡCollagen-decoy group.
The secretion of  IFN-γ and IL-10
As shown in Table 3, compared with control group, the 
secreted IFN-γ in LPS stimulation group was higher 
(p<0.05), and the secreted IFN-γ in decoy induction 
group was lower (p<0.05). The secreted IFN-γ in 
LPS stimulation+Decoy induction group exhibited no 
significant difference with that in the decoy induction 
group, but was significantly lower than that in LPS 
stimulation group (p<0.05). The addition of  serum 
of  healthy person exhibited stronger IFN-γ secretion 
than that for the addition of  Bovine TypeⅡCollagen 
(p<0.05).
Table 3 The influence of  DC towards the secretion of  IFN-r by lymphocytes (Meanxx±S.D.)
 
Groups n OD values IFN-r（ng/L）
Control 4 0.407±0.180 385±34
LPS stimulation 4 0.589±0.196 666±58*




Bovine Type Ⅱ Collagen 
-Decoy
4 0.427±0.193 416±54
Bovine Type Ⅱ Collagen 
–Decoy (plus serum)
4 0.714±0.207 859±75△
Note: *, p<0.05, compared with control group; #, p<0.05, compared with LPS stimulation group; △,p<0.05, 
compared with Bovine TypeⅡCollagen-decoy group.
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For IL-10 secretion (Table 4), no significantly difference 
was observed between decoy induction group and 
control group. The secretion of  IL-10 in decoy group 
and LPS stimulation+decoy induction group was 
higher than LPS stimulation group (p<0.05). The 
addition of  serum of  healthy person exhibited weaker 
IL-10 secretion than that for the addition of  Bovine 
TypeⅡCollagen (p<0.05).
Table 4 The influence of  DC towards the secretion of  IL-10 by lymphocytes (Meanxx±S.D.)
Groups n
OD values IL-10（ng/L）
Control 4 0.411±0.172 9.45±0.90
LPS stimulation 4 0.370±0.169 8.50±0.77




Bovine Type Ⅱ Collagen 
-Decoy
4 0.421±0.177 9.83±1.07
Bovine Type Ⅱ Collagen 
-Decoy(plus serum)
4 0.289±0.169 5.08±0.80#
Note: *, p<0.05, compared with LPS stimulation group; #, p<0.05, compared with Bovine TypeⅡCollagen-decoy 
group.
Discussion
NF-κB is a transcription regulation factor which is 
involved in the body defense, cell differentiation and 
apoptosis through regulating the transcription of  
cytokines, adhesion molecules, and immunologic 
receptors. The activation of  NF-κB plays a key role in the 
maturation of  DC [9]. Decoy ODN, a recently developed 
genetic method, can completely block transcription 
factor function. Compared with more classical methods 
(e.g. chloramphenicol acetyltransferase, luciferase 
constructs, etc.), this method was inexpensive [10].
The addition of  GM-CSF and IL-4 can induce the 
formation of  immature DCs. However, this kind of  
immature DCs is not easily regulated, and many factors 
(e.g. Inflammation, LPS, IFN-r, etc.) can activate 
immature DCs to become mature. The present study 
utilized the strong capability of  immature DC to absorb 
the antigen, and transfect NF-κB Decoy ODN into the 
nucleus of  DC [11]. The transfection of  NF-κB Decoy 
ODN made DC to maintain the following immature 
state: 1) The adhered and hairlike cells are more in 
decoy group than control group; 2) In NF-κB Decoy 
ODN group, the expression of  CD80 and CD86 in cell 
surface is lower than that in control group. Additionally, 
LPS stimulation was also used to stability of  immatured 
DCs, and the results showed the expression of  CD80 
and CD86 was not significantly altered, indicating 
that decoy-induced DC was very stable. This result 
was similar with the previous literatures [11,12]. The 
activation of  lymphocytes depends the maturation 
of  DC. The present study showed that the activation 
capability in decoy group was lower than control group 
and LPS stimulation group, and the expression of  IFN-r 
was significantly inhibited in decoy group, furtherly 
indicating the stability of  decoy-induced immatured 
DC [13].
With the increased study for rheumatoid arthritis (RA), 
some antigens related with RA have been detected, 
including type II collagen and glucose-6-phosphate 
isomerase (GPI) [14,15]. The tolerogenic DC vaccine 
with specific antigen will be a promising therapy for 
RA. Immature DCs have very strong capability to 
capture antigen. Once captured by immature DCs, 
the proteinase in lysosome can digest the antigen into 
peptides containing 14-20 amino acids which furtherly 
formed complex with MHG-II and were secreted into 
cell surface. The present study prepared the tolerogenic 
DC loaded with Bovine TypeⅡCollagen antigen which 
did not affect the low expression of  CD80 and CD86, 
indicating that the loaded Bovine TypeⅡCollagen did 
not affect the status of  tolerogenic DC.
Conclussion
The tolerogenic DC was successfully constructed 
through NF-κB Decoy ODN method towards isolated 
spleen cells. This tolerogenic DC has low stimiulation 
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capability towards lymphocytes, and this properties 
can be difficult to be reversed by LPS stimulation. 
After loaded with Bovine TypeⅡCollagen antigen, this 
tolerogenic DC vaccine can be successfully applied to 
RA treatment. 
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